Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing

We recently published an article titled Why These 10 Small-Cap Stocks Are Skyrocketing. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other small-cap stocks.

Wall Street is increasing its bet on small-cap stocks, suggesting that the sector will potentially outperform in 2025. The reasons behind this are simple. While stable rates will be one of the biggest tailwinds for small-cap names, analysts also expect stronger valuations and solid earnings growth from the sector in the year ahead. Most importantly, with expectations tied to the market broadening, investors and analysts are excited to see how the market conditions pan out for small caps.

Ten companies in diverse sectors such as the financials, healthcare, technology, and energy industries, locked in overall positive market gains due to supportive market conditions, macroeconomic environment, and growth potential. That said, let’s take a look at the 10 small-cap stocks that happen to be skyrocketing.

To come up with the 10 names, we only considered stocks with a market capitalization between $1 billion and $10 billion. We then shortlisted the stocks based on their performance in the past quarter and picked the top 10 with the highest 30-day return from December 16, 2024, to January 16, 2025.

A close-up view of a technician wearing protective gloves while installing a mechanical thrombectomy system.

Inari Medical, Inc. (NASDAQ:NARI)

30-day Return as of January 16, 2024: 40%

Inari Medical, Inc. (NASDAQ:NARI) registered impressive gains following a buyout deal from Stryker. The stock gained 40% in the past 30 days, going from $56.75 on December 16, 2024, to $79.4 on January 16.

The medical device company has treated more than 100,000 patients so far and offers a diverse range of products in mechanical thrombectomy. In addition to that, the mechanical thrombectomy industry is also expected to register solid growth over the next few years, fueling NARI’s position in the market.

The company’s premium valuation of $4.9 billion, following the buyout, has immensely contributed to its surge. However, the aftermath of the acquisition is yet to play out and investors are keen to see where the stock goes following the decision.

Overall NARI ranks 3rd on our list of the small-cap stocks that are skyrocketing right now. While we acknowledge the potential of NARI as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NARI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.